Judith Marsh Selected Research

Judith Marsh Research Topics

Disease

26	Aplastic Anemia (Anemia, Hypoplastic) 02/2022 - 04/2007
7	Neoplasms (Cancer) 01/2020 - 12/2005
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 10/2005
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 12/2005
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 04/2007
3	idiopathic Aplastic anemia 01/2019 - 09/2009
2	Bone Marrow Failure Disorders 10/2021 - 01/2011
2	Viremia 10/2020 - 10/2019
2	Chronic Renal Insufficiency 01/2020 - 12/2004
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2020 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2010 - 01/2004
1	Opportunistic Infections (Opportunistic Infection) 01/2024
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2021
1	Virus Diseases (Viral Diseases) 10/2020
1	Osteonecrosis (Kienbock's Disease) 01/2020
1	COVID-19 01/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2019
1	Multiple Sclerosis 10/2019
1	Paraproteinemias (Monoclonal Gammopathy) 10/2019
1	Lymphoma (Lymphomas) 01/2019
1	Membranous Glomerulonephritis (Membranous Nephropathy) 04/2018
1	Autosomal Recessive 3 Severe Congenital Neutropenia 10/2015
1	Bronchiolitis Obliterans Syndrome 10/2014
1	Leukemia 09/2014
1	Hematologic Diseases (Blood Diseases) 06/2014
1	Autosomal Dominant Dyskeratosis Congenita 08/2007
1	Stroke (Strokes) 06/2007
1	Sickle Cell Anemia (Hemoglobin S Disease) 06/2007
1	Pathologic Complete Response 12/2005
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2004

Drug/Important Bio-Agent (IBA)

8	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 06/2010
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 10/2005
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 04/2007
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 10/2005
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 06/2010
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2011
2	Alemtuzumab (Campath)FDA Link 01/2019 - 03/2010
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2011 - 08/2007
2	telomerase RNA (bTR)IBA 01/2011 - 08/2007
2	fludarabineIBA 06/2010 - 09/2009
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	Epstein-barr virus BALF5 proteinIBA 10/2019
1	Phospholipase A2 ReceptorsIBA 04/2018
1	eculizumab FDA Link 01/2018
1	Blood Group Antigens (Blood Groups)IBA 05/2015
1	IronIBA 06/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2011
1	AntigensIBA 06/2007
1	Erythropoietin FDA Link 12/2004
1	SteroidsIBA 01/2004

Therapy/Procedure

19	Transplantation 02/2022 - 12/2005
9	Stem Cell Transplantation 10/2021 - 01/2004
9	Hematopoietic Stem Cell Transplantation 01/2021 - 09/2009
5	Therapeutics 10/2014 - 01/2004
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2021 - 01/2019
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2024
1	Aftercare (After-Treatment) 09/2014
1	Isogeneic Transplantation 11/2013
1	Cell Transplantation 06/2007
1	Homologous Transplantation 12/2005
1	Drug Therapy (Chemotherapy) 01/2004